D-0003-2026 Class II Terminated

Recalled by RC Outsourcing, LLC — Lowellville, OH

FDA drug recall D-0003-2026 was initiated by RC Outsourcing, LLC on Sep 22, 2025 and is designated Class II. Reason for recall: Lack of assurance of sterility. The recall status is terminated (terminated Jan 5, 2026). Affected quantity: 2,669 syringes.

Recall details

Product Type
Drugs
Report Date
Oct 15, 2025
Initiation Date
Sep 22, 2025
Termination Date
Jan 5, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,669 syringes

Product description

Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.

Reason for recall

Lack of assurance of sterility.

Distribution pattern

Nationwide in the US

Code information

Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0003-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0003-2026. Report a data issue: hello@regdatalab.com.